Shareholder Alert: The Ademi Firm investigates whether PharmChem, Inc. is obtaining a Fair Price for its Public Shareholders
Shareholder Alert: The Ademi Firm investigates whether PharmChem, Inc. is obtaining a Fair Price for its Public Shareholders |
| [21-July-2025] |
MILWAUKEE, July 21, 2025 /PRNewswire/ -- The Ademi Firm is investigating PharmChem (OTC: PCHM) for possible breaches of fiduciary duty and other violations of law in its transaction with Alcohol Monitoring Systems.
Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995. There is no cost or obligation to you. In the transaction, shareholders of PharmChem will receive $3.75 per share in cash. PharmChem insiders will receive substantial benefits as part of change of control arrangements. The transaction agreement unreasonably limits competing transactions for PharmChem by imposing a significant penalty if PharmChem accepts a competing bid. We are investigating the conduct of the PharmChem board of directors, and whether they are fulfilling their fiduciary duties to all shareholders. We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes. Contacts Ademi & Fruchter LLP
SOURCE Ademi LLP | ||
Company Codes: OTC-PINK:PCHM |
View original content to download multimedia:
